VILLA, STEFANIA
VILLA, STEFANIA
Dipartimento di Scienze Farmaceutiche
Towards a safe treatment of Insulin Resistance: γ-hydroxy lactone-based derivatives as PPARγ non-agonists
2024 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, E.M.A. Fassi, G. Grazioso, F. Meneghetti, S. Villa
Exploring the Inhibition of Iron Acquisition in M. abscessus as a Potential Anti-Virulence Strategy in People with Cystic Fibrosis
2024 M. Mori, A. Tresoldi, G. Cazzaniga, A. Gelain, G. Stelitano, M. Cocorullo, L.R. Chiarelli, P. Delre, G.F. Mangiatordi, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti
Targeting iron acquisition in M. abscessus: a new strategy for the development of anti-virulence agents for cystic fibrosis patients
2024 M. Mori, A. Tresoldi, G. Cazzaniga, A. Gelain, G. Stelitano, M. Cocorullo, L.R. Chiarelli, P. Delre, G.F. Mangiatordi, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti
Anti-biofilm efficacy of novel silica-based nanoparticles functionalized withnatural derivatives for surface coating
2024 G. Cazzaniga, C. Catto', M. Mori, P. Hayes, D. Yan, N.H. Arachchi, F. Villa, F. Cappitelli, A. Melocchi, L. Zema, S. Crespi, P.J. Molino, S. Villa, A. Gelain
Novel Non-peptide Uracil-derived Human Gonadotropin-Releasing Hormone Receptor Antagonists
2024 S. Ciceri, E.M.A. Fassi, V. Vezzoli, M. Bonomi, D. Colombo, P. Ferraboschi, G. Grazioso, P. Grisenti, S. Villa, C. Castellano, F. Meneghetti
Eco-Friendly Bio-Based Solvents for the Acetylation of the Amino Group of Amino Acids
2024 G. Cazzaniga, A. Tresoldi, A. Gelain, F. Meneghetti, M. Mori, S. Villa
A hit expansion of 3-benzamidopyrazine-2-carboxamide: Toward inhibitors of prolyl-tRNA synthetase with antimycobacterial activity
2024 V. Sukanth Kumar Pallabothula, N. Taimur Abdalrahman, M. Mori, A. Hossein Fekri, O. Janďourek, K. Konečná, P. Paterová, M. Novák, P. Dudášová-Hatoková, P. Štěrbová-Kovaříková, C. Castellano, F. Meneghetti, S. Villa, J. Kuneš, M. Juhás, J. Zitko
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus
2024 M. Mori, M. Cocorullo, A. Tresoldi, G. Cazzaniga, A. Gelain, G. Stelitano, L.R. Chiarelli, M. Tomaiuolo, P. Delre, G.F. Mangiatordi, M. Garofalo, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti
Optimizing the drug discovery process for the development of MbtI inhibitors as promising anti-virulence agents against TB
2023 M. Mori, G. Cazzaniga, A. Tresoldi, A. Gelain, L.R. Chiarelli, G. Stelitano, M. Bellinzoni, S. Villa, F. Meneghetti
Discovery of novel SIRT5 activators as potential anti-inflammatory agents
2023 A. Gelain, . Mori, G. Cazzaniga, F. Meneghetti, . Wong, L. Jun Yan, P.S. Coghi, S. Villa
Natural and nature-inspired compounds targeting E. coli WrbA as antibiofilm agents: computational studies, synthesis, and biological evaluation
2023 M. Mori, S. Villa, A. Ratti, F. Meneghetti, G. Roda, A. Gelain, F. Villa, E.M.A. Fassi, F. Forlani, G. Grazioso
Ironing out Fe3+ acquisition in M. abscessus: a new strategy to target virulence factors in non-tuberculous mycobacteria
2023 M. Mori, A. Tresoldi, G. Cazzaniga, A. Gelain, G. Stelitano, M. Cocorullo, L.R. Chiarelli, P. Delre, G.F. Mangiatordi, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti
Unlocking the Antibiofilm Potential of Natural Compounds by Targeting the NADH:quinone Oxidoreductase WrbA
2023 A. Ratti, E.M.A. Fassi, F. Forlani, M. Zangrossi, M. Mori, F. Cappitelli, G. Roda, S. Villa, F. Villa, G. Grazioso
γ-hidroxy-lactone derivatives as ppar-γ non-agonists blocking cdk5-mediated phosporylation for a safer anti-diabetic treatment
2023 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, I. Bassanini, S. Romeo, E.M.A. Fassi, M. Quaglia, G. Grazioso, F. Meneghetti, S. Villa
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS.
2023 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, I. Bassanini, S. Romeo, E.M.A. Fassi, G. Grazioso, M. Quaglia, F. Meneghetti, S. Villa
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS
2023 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, I. Bassanini, S. Romeo, E.M.A. Fassi, G. Grazioso, M. Quaglia, F. Meneghetti, S. Villa
Structural Study of a New MbtI-Inhibitor Complex: Towards an Optimized Model for Structure-Based Drug Discovery
2023 M. Mori, S. Villa, L.R. Chiarelli, F. Meneghetti, M. Bellinzoni
Mechanistic Insights into the Antibiofilm Mode of Action of Ellagic Acid
2023 A. Ratti, E.M.A. Fassi, F. Forlani, M. Mori, F. Villa, F. Cappitelli, J. Sgrignani, G. Roda, A. Cavalli, S. Villa, G. Grazioso
Iron Acquisition and Metabolism as a Promising Target for Antimicrobials (Bottlenecks and Opportunities): Where Do We Stand?
2023 G. Stelitano, M. Cocorullo, M. Mori, S. Villa, F. Meneghetti, L. Roberto Chiarelli
Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria
2023 M. Mori, G. Stelitano, G. Cazzaniga, A. Gelain, A. Tresoldi, M. Cocorullo, M. Roversi, L.R. Chiarelli, M. Tomaiuolo, P. Delre, G. Felice Mangiatordi, A. Griego, L. Rizzello, A. Cassetta, S. Covaceuszach, S. Villa, F. Meneghetti